Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_01702
Species: Homo sapiens
Position : chr9:133401000-133404500
Year: 2016
Title: BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: ovarian carcinoma
PMID:  27803105
MONDO: MONDO:0005140
Tissue: breast
Tissue Ontology ID: UBERON:0000310
Cell Source: ZR-75-1
CVCL ID: CVCL_0588
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Enhancer activity assay, Functional perturbation assay, Chromatin interaction assay; In vivo functional validation
High Throughput Method: ChIP-seq, RNA-seq, 3C
Low Throughput Method: Luciferase Reporter Assay, CRISPR Knockout, RT-RT-qPCR; In vivo phenotyping
About Target Gene
Target gene : ALDH1A1
About TF
TF name : BRD4
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg19)
No overlapping enhancers found in hg19 at this locus.
Expression of Target Genes for the Enhancer